missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30144119

MAP3K8/Tpl2/COT Antibody (OTI3D9), CoraFluor™ 1, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals (Bio-Techne) NBP2-72589CL1

Product Code. 30144119

  • £870.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

MAP3K8/Tpl2/COT Monoclonal antibody specifically detects MAP3K8/Tpl2/COT in Human,Mouse,Rat samples. It is validated for Western Blot
TRUSTED_SUSTAINABILITY
Specifications

Specifications

MAP3K8/Tpl2/COT
Monoclonal
CoraFluor 1
Cancer Osaka thyroid oncogene, c-COT, cot (cancer Osaka thyroid) oncogene, COTMEKK8, EC 2.7.11.25, ESTF, ESTFLJ10486, Ewing sarcoma transformant, mitogen-activated protein kinase kinase kinase 8, Proto-oncogene c-Cot, proto-oncogene serine/threoine protein kinase, Serine/threonine-protein kinase cot, Tpl-2, TPL2, Tumor progression locus 2, tumor progression locus-2
Human recombinant protein fragment corresponding to amino acids 277-461 of human MAP3K8(NP_005195) produced in E.coli.
0.1 mL
Angiogenesis, Cancer, Protein Kinase
1326
Store at 4°C in the dark. Do not freeze.
IgG1
Western Blot
OTI3D9
PBS
Mouse
Immunogen affinity purified
RUO
Primary
Human, Mouse, Rat
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.